Bright Minds Biosciences Inc. (CSE:DRUG)
Canada flag Canada · Delayed Price · Currency is CAD
122.71
+2.96 (2.47%)
At close: Jan 9, 2026

Bright Minds Biosciences Ratios and Metrics

Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212019 - 2020
Period Ending
Jan '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 2019 - 2020
9565987828107
Upgrade
Market Cap Growth
15082.09%9016.50%-19.09%-71.17%-73.71%-
Upgrade
Enterprise Value
873547001985
Upgrade
Last Close Price
122.7184.391.472.158.5045.20
Upgrade
PB Ratio
11.657.291.191.232.675.51
Upgrade
P/TBV Ratio
11.657.291.191.232.675.52
Upgrade
Debt / Equity Ratio
0.000.000.020.010.01-
Upgrade
Quick Ratio
35.6835.6810.9224.168.0031.12
Upgrade
Current Ratio
36.1036.1011.3224.268.1131.38
Upgrade
Return on Equity (ROE)
-27.93%-27.93%-46.18%-86.02%-99.95%-85.94%
Upgrade
Return on Assets (ROA)
-18.80%-18.80%-25.28%-47.45%-57.32%-51.52%
Upgrade
Return on Capital (ROIC)
-19.38%-19.38%-26.62%-51.86%-61.21%-53.54%
Upgrade
Return on Capital Employed (ROCE)
-16.60%-16.60%-47.10%-109.10%-138.80%-44.40%
Upgrade
Earnings Yield
-1.28%-2.04%-42.70%-90.90%-53.20%-8.09%
Upgrade
Buyback Yield / Dilution
-59.58%-59.58%-15.87%-50.58%-37.64%-148.42%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.